Press release
Rising Gout Incidence Driving Growth In Krystexxa Market: Major Factor in the Transformation of the Krystexxa Market in 2025
Krystexxa Market Size
In recent times, the market size for krystexxa has seen a HCAGR of $XX. The projections show a growth from $XX million in 2024 to $XX million in 2025, with a Compound Annual Growth Rate (CAGR) of $XX%. The historic period growth has been driven by factors such as an increasing geriatric population, a surge in clinical studies, growing prevalence of chronic and refractory conditions, a rising trend of telemedicine in the healthcare system, and an increasing coverage for biological treatments.
The market size of krystexxa is anticipated to experience a future compound annual growth rate of $XX% in the coming years. By 2029, it's predicted to build up to a value of $XX million. This growth can be linked to a surge in chronic diseases prevalence, a rising global population, the increasing need for the use of intravenous pegloticase, a rise in gout incidents, and heightened healthcare spending. Noteworthy trends projected for the forecast period include a movement toward subcutaneous delivery methods, the incorporation of artificial intelligence in clinical trials, technological progression, innovative product introduction, as well as advances in pegylation technology.
What Key Elements Are Boosting Growth in the Krystexxa Market?
The surge in the occurrence of gout disease is anticipated to drive the expansion of the Krystexxa market in the future. Gout disease is a type of arthritis resulting from the accumulation of uric acid crystals in the joints, which leads to discomfort, inflammation, and swelling. The rising number of gout disease cases can be tied to a variety of factors, including unhealthy eating habits, obesity, aging, specific medications, genetic factors, chronic kidney disease, a lack of physical activity, and associated conditions such as hypertension and diabetes. Krystexxa (pegloticase) assists gout patients by reducing the levels of uric acid in their bloodstream, specifically focusing on chronic gout that doesn't respond to traditional treatments. This ultimately diminishes the frequency and intensity of gout outbreaks, offering respite from the painful symptoms linked with the disease. For instance, in June 2024, the Australian Institute of Health and Welfare, a government agency based in Australia, reported that in 2022, gout was implicated in 573 deaths in Australia, amounting to 2.2 fatalities per 100,000 individuals. This made up 0.3% of all deaths and accounted for 5.5% of all fatalities attributed to musculoskeletal conditions. Consequently, the escalating incidence of gout disease is contributing to the growth of the Krystexxa market.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20134&type=smp
Who Are the Major Industry Players Fueling Krystexxa Market Expansion?
Major companies operating in the krystexxa market include Amgen Inc.
Which Key Developments Are Influencing the Krystexxa Market?
A prevailing trend in the krystexxa market is the concentration on combination therapy to optimize effectiveness, curtail the development of anti-drug antibodies, and advance patient results in the control of unchecked gout. Combination therapy implies the combined usage of two or more drugs or treatments to increase effectiveness and better patient outcomes. It is traditionally employed to address various facets of a disease or condition. For instance, in July 2022, Horizon Therapeutics, a biotechnology firm based in Ireland, was granted the supplemental biologics license application (sBLA) by the Food and Drug Administration, a US federal agency, to expand the label to encompass Krystexxa (pegloticase) injection coupled with methotrexate. When utilized together with methotrexate, Krystexxa (pegloticase) injection treats adult patients suffering from uncontrollable chronic gout. This combination therapy improves effectiveness by mitigating the generation of anti-drug antibodies and enhancing the patient's response.
How Is the Segmentation of the Krystexxa Market Defined?
The krystexxa market covered in this report is segmented -
1) By Formulation: Injectable Formulation (Lyophilized Powder), Ready-To-Use Solutions
2) By Indication: Treatment Of Chronic Gout, Management Of Hyperuricemia In Gout Patients, Treatment Of Refractory Gout
3) By Patient Demographics: Adult Patients, Elderly Patients, Patients With Comorbid Conditions
4) By Distribution Channel: Direct Sales, Wholesalers And Distributors, Retail Pharmacies, Online Pharmacies
5) By End User: Hospitals, Specialty Clinics, Rheumatology Practices, Home Healthcare Providers
Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/krystexxa-global-market-report
What Is the Leading Region in the Krystexxa Market?
North America was the largest region in the krystexxa market in 2024. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the krystexxa market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
What Is Covered In The Krystexxa Global Market Report?
- Market Size Analysis: Analyze the krystexxa Market Size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the krystexxa market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall krystexxa market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the krystexxa market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20134
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Rising Gout Incidence Driving Growth In Krystexxa Market: Major Factor in the Transformation of the Krystexxa Market in 2025 here
News-ID: 3876820 • Views: …
More Releases from The Business Research Company
In-Depth Analysis of the Metaverse In E-Commerce Market: Growth Opportunities, K …
What market dynamics are playing a key role in accelerating the growth of the metaverse in e-commerce market?
The expansion of the metaverse in e-commerce markets is forecasted to be fueled by the growing popularity of social commerce. Social commerce pertains to the use of social media channels for enhancing online purchasing and selling via integrated shopping functionalities. The upsurge of social commerce can be attributed to heightened social media activity,…
A Deep Dive into Mesotherapy Market 2025: Key Drivers, Growth Factors, and Proje …
Which drivers are expected to have the greatest impact on the over the mesotherapy market's growth?
The surging preference for less invasive medical approaches is anticipated to fuel the expansion of the mesotherapy market. These procedures utilize slight incisions or non-invasive techniques for operations or treatments, resulting in minimal tissue harm, accelerated healing periods, and lessens discomfort after surgery compared to conventional surgical methods. The rise in these processes is attributed…
Rising Incidence Of Medical Accidents Fuels Growth In The Medical Professional L …
What industry-specific factors are fueling the growth of the medical professional liability insurance market?
The rising occurrence of medical mishaps is predicted to fuel the expansion of the medical professional liability insurance market in the future. Medical mishaps, otherwise referred to as medical errors or adverse events, denote unintentional injuries or complications arising from medical attention or treatment. Various factors, such as human error, system breakdowns, or unpredicted complications contribute to…
Surge In Clinical Trials To Drive Growth In Contract Research Organization Marke …
What combination of drivers is leading to accelerated growth in the medical device contract research organization (cro) market?
The rise in clinical trials is anticipated to boost the growth of the medical device contract research organization (CRO) market in the future. Clinical trials, which are research studies on human subjects to test the safety and efficacy of new medical therapies, interventions, or diagnostic methods, are experiencing growth due to the increasing…
More Releases for Krystexxa
According to DelveInsight's' estimates, Gout Market in 7MM is expected to show p …
"The increase in Gout Market size is a direct consequence of an increase in R& D activity, increasing prevalent population, expected commercial success of upcoming therapies in the 7MM"
The potential drugs recently launched in the Gout Market or expected to get launched in the market during the study period 2019-2032
The Gout Market Insights report from DelveInsight provides a thorough understanding of the Gout Market size by treatment, epidemiology, emerging therapies,…
Beacon Infusion Opens New Infusion Location in Hackensack, NJ
PRESS INFORMATION
FOR IMMEDIATE RELEASE: July 17, 2020
Contact:
Beacon Infusion Healthcare Services
www.beaconinfusion.com
833-223-2266
Beacon Infusion Opens New Infusion Location in Hackensack, NJ
Rapid growth and expanding patient base accelerate need for new locations
HACKENSACK, NJ JULY 17, 2020 – Beacon Infusion Healthcare Services, a pioneer in national freestanding infusion centers providing infusion and long-acting injectable care, announces the addition of a brand-new location to serve its growing patient base.
This is Beacon Infusion’s second location in New…
Gout Therapeutics Market Size, Share, Trends, Growth, Regional Outlook and Forec …
According to the latest market report published by Credence Research, Inc. “Gout Therapeutics Market - Growth, Future Prospects and Competitive Analysis, 2017 - 2025” the global gout therapeutics market, expanding at a CAGR of 15.6% from 2017 to 2025.
Browse the full report Gout Therapeutics Market - Growth, Future Prospects and Competitive Analysis, 2017 – 2025 report at http://www.credenceresearch.com/report/gout-therapeutics-market
Market Insights
Gout is a complex form of inflammatory arthritis characterized by acute intermittent…
Gout Therapeutics Market will Reflect Significant Growth Prospects during 2017 - …
Global Gout Therapeutics Market: Overview
Gout is a physical conditions that affects the patient’s ability to move, often also termed as unwalkable disease, and it has been around for centuries. But in the recent times, especially in the U.S., the prevalence of gout has increased to greater extents, which is a reflection of growing population with obesity, smoking habits, and increased intake of alcohol. Increased level of uric acid in the…
Gout Therapeutics Market - Future Growth & Forecast 2017-2025
Global Gout Therapeutics Market: Overview
Gout is a physical conditions that affects the patient’s ability to move, often also termed as unwalkable disease, and it has been around for centuries. But in the recent times, especially in the U.S., the prevalence of gout has increased to greater extents, which is a reflection of growing population with obesity, smoking habits, and increased intake of alcohol. Increased level of uric acid in the…
Gout Therapeutics Market- Future Market,Growth and Forecast 2017 - 2025
Global Gout Therapeutics Market: Overview
Gout is a physical conditions that affects the patient’s ability to move, often also termed as unwalkable disease, and it has been around for centuries. But in the recent times, especially in the U.S., the prevalence of gout has increased to greater extents, which is a reflection of growing population with obesity, smoking habits, and increased intake of alcohol. Increased level of uric acid in the…
